The second hit is an event that compromises the blood-brain barrier (BBB), such as tumor-induced production of other antibodies, allowing the AQP4-IgG to enter the central nervous system and cause disease, which also explains cases where the tumor itself is AQP4-negative (29, 30). This evidence concerns the gene AQP4 and neoplasm.